Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

OBJECTIVES: To compare the in vitro and in vivo activities of a 4:1 (w/w) fosfomycin/tobramycin combination (FTI) with those of fosfomycin and tobramycin alone against cystic fibrosis (CF) and non-CF bronchiectasis pathogens. METHODS: Clinical isolates of CF Pseudomonas aeruginosa, Staphylococcus au...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLeod, David L., Barker, Lynn M., Sutherland, Jennifer L., Moss, Suzanne C., Gurgel, Jesse L., Kenney, Thomas F., Burns, Jane L., Baker, William R.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740636/
https://www.ncbi.nlm.nih.gov/pubmed/19679597
http://dx.doi.org/10.1093/jac/dkp282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740636/
https://www.ncbi.nlm.nih.gov/pubmed/19679597
http://dx.doi.org/10.1093/jac/dkp282

Ejemplares similares